The finding of somatic NR5A1 gene mutations (gain of allele substitutions) in 10% of the ovarian tumors (Fig. 2) is striking, given the fact that we interrogated only three base pairs of the NR5A1 gene in these assays (the three SNP positions). This evidence concerns the gene NR5A1 and ovarian neoplasm.